KP Tissue Releases Fourth Quarter 2014 and Full Year 2014 Financial Results

KP Tissue Inc. (“KPT”) (TSX:KPT) reports the Q4 2014 and full year 2014 Financial and Operational Results of KPT and Kruger Products L.P. (KPLP):

Q4 2014 Highlights
—  Revenue increased by 14.7% to $278.6 million in Q4 2014 compared to $242.9 million in Q4 2013
—  EBITDA of $30.4 million in Q4 2014, up from $28.3 million in Q4 2013
—  Maintained number one overall consumer market share in Canada
—  TAD Product EBITDA contribution of $9.1 million

Full Year 2014 Highlights
—  Revenue increased by 9.5% to $1,046.2 million in 2014 compared to $955.3 million in 2013
—  EBITDA of $121.6 million in 2014, up from $116.2 million in 2013
—  TAD Product EBITDA contribution of $26.9 million
—  At year-end, cash & cash equivalents stood at $51.8 million

“In 2014, we reached an important milestone with more than one billion dollars in revenues. Despite a competitive market environment, we remained the clear leader in the Canadian tissue market. In the U.S., TAD Products performed very well and were a significant contributor to consolidated EBITDA. In the Away-From-Home (AFH) business, we extended our North American platform with the acquisition of Metro Paper,” said Mario Gosselin, CEO of KP Tissue and KPLP.

“Despite negative pressure from higher pulp and natural gas prices, and from the weaker Canadian dollar, we reported EBITDA for Fiscal 2014 of $121.6 million, an increase of 4.6% over last year. The increase in EBITDA was related to the Consumer segment which was in turn primarily driven by TAD Products.
read more/source:  http://ir.kptissueinc.com/releasedetail.cfm?ReleaseID=901230

Back To Top
×Close search
Search